Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

DNA ploidy: a prognostic factor of response to chemotherapy and survival in metastatic gastric adenocarcinoma.

Syrios J, Kechagias G, Agrogiannis G, Xynos ID, Kavantzas N, Lazaris AC, Amptoulach S, Mourati A, Sougioultzis S, Patsouris ES, Tsavaris N.

Anticancer Res. 2013 Mar;33(3):1209-14. Erratum in: Anticancer Res. 2013 Apr;33(4):1783.

PMID:
23482804
2.

Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma?

Filipe MI, Rosa J, Sandey A, Imrie PR, Ormerod MG, Morris RW.

Hum Pathol. 1991 Apr;22(4):373-8.

PMID:
2050371
3.
4.

DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.

Santoro E, Carboni M, Catarci M, Carlini M, Carboni F, Zupi G, Vecchione A, D'Agnano I, Giannarelli D, Santoro R, Garofalo A.

Hepatogastroenterology. 1997 May-Jun;44(15):826-37.

PMID:
9222700
5.

Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer.

Setälä LP, Nordling S, Kosma VM, Lipponen PK, Eskelinen MJ, Hollmén SM, Syrjänen KJ, Alhava EM.

Anal Quant Cytol Histol. 1997 Dec;19(6):524-32.

PMID:
9893908
6.

Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.

Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S.

Anticancer Res. 1997 Jul-Aug;17(4B):2923-6.

PMID:
9329565
7.

Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.

Tsavaris N, Kavantzas N, Tsigritis K, Xynos ID, Papadoniou N, Lazaris A, Kosmas C, Agrogiannis G, Dokou A, Felekouras E, Antoniou E, Polyzos A, Sarantonis J, Tsipras H, Karatzas G, Papalambros A, Patsouris ES.

BMC Cancer. 2009 Jul 31;9:264. doi: 10.1186/1471-2407-9-264.

8.
9.

Prognostic value of DNA ploidy in primary gastric leiomyosarcoma.

Suzuki H, Sugihira N.

Br J Surg. 1993 Dec;80(12):1549-50.

PMID:
8298922
10.

Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma: univariate and multivariate analysis.

Tonouchi H, Matsumoto K, Kinoshita T, Itoh H, Suzuki H.

Dig Surg. 1998;15(6):687-92.

PMID:
9845638
11.
12.

Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma.

Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S.

Oncology. 1996 May-Jun;53(3):182-91.

PMID:
8643219
13.

DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer.

Korenaga D, Okamura T, Saito A, Baba H, Sugimachi K.

Cancer. 1988 Jul 15;62(2):309-13.

14.

Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.

Russo A, Bazan V, Migliavacca M, Zanna I, Tubiolo C, Tumminello FM, Dardanoni G, Cajozzo M, Bazan P, Modica G, Latteri M, Tomasino RM, Colucci G, Gebbia N, Leto G.

Clin Cancer Res. 2000 Jan;6(1):178-84.

15.

Flow cytometric analysis of nuclear DNA heterogeneity in gastric cancer.

Imada T, Yamamoto Y, Fukuzawa K, Rino Y, Suda T, Moriwaki Y, Akiyama H, Doi T, Kito F, Takemura H.

Jpn J Clin Oncol. 1997 Aug;27(4):221-6.

PMID:
9379507
16.

Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis.

Rugge M, Sonego F, Panozzo M, Baffa R, Rubio J Jr, Farinati F, Nitti D, Ninfo V, Ming SC.

Cancer. 1994 Feb 15;73(4):1127-33.

17.

Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.

Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA.

J Surg Oncol. 2003 Apr;82(4):247-55.

PMID:
12672009
18.

Prognostic significance of DNA content with special reference to age in gastric cancer.

Baba H, Korenaga D, Okamura T, Saito A, Watanabe A, Sugimachi K.

Cancer. 1989 May 1;63(9):1768-72.

19.
20.

Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.

Lanza G, Gafà R, Santini A, Maestri I, Dubini A, Gilli G, Cavazzini L.

Cancer. 1998 Jan 1;82(1):49-59.

PMID:
9428479

Supplemental Content

Support Center